Moderna shares fall despite promising data from cancer vaccine trial
Sopa Images | Lightrocket | Getty ImagesShares of Moderna fell Monday as Wall Street chewed over new trial results on the personalized cancer vaccine it is developing with Merck. Merck's shares were relatively flat.The experimental mRNA…